» Articles » PMID: 34408261

The Size and Culturability of Patient-generated SARS-CoV-2 Aerosol

Abstract

Background: Aerosol transmission of COVID-19 is the subject of ongoing policy debate. Characterizing aerosol produced by people with COVID-19 is critical to understanding the role of aerosols in transmission.

Objective: We investigated the presence of virus in size-fractioned aerosols from six COVID-19 patients admitted into mixed acuity wards in April of 2020.

Methods: Size-fractionated aerosol samples and aerosol size distributions were collected from COVID-19 positive patients. Aerosol samples were analyzed for viral RNA, positive samples were cultured in Vero E6 cells. Serial RT-PCR of cells indicated samples where viral replication was likely occurring. Viral presence was also investigated by western blot and transmission electron microscopy (TEM).

Results: SARS-CoV-2 RNA was detected by rRT-PCR in all samples. Three samples confidently indicated the presence of viral replication, all of which were from collected sub-micron aerosol. Western blot indicated the presence of viral proteins in all but one of these samples, and intact virions were observed by TEM in one sample.

Significance: Observations of viral replication in the culture of submicron aerosol samples provides additional evidence that airborne transmission of COVID-19 is possible. These results support the use of efficient respiratory protection in both healthcare and by the public to limit transmission.

Citing Articles

Detection of SARS-CoV-2 in bioaerosols and surface samples from healthcare facilities in Klang Valley, Malaysia.

Robat R, Nazakat R, Rashid S, Ismail R, Hasni N, Mohamad N Sci Rep. 2025; 15(1):7192.

PMID: 40021779 PMC: 11871134. DOI: 10.1038/s41598-025-91566-z.


Association between in situ ventilation and human-generated aerosol exposure in meatpacking plants during the COVID-19 pandemic.

Santarpia J, Lau J, Shom D, Ratnesar-Shumate S, Carnes E, Santarpia G PLoS One. 2024; 19(12):e0314856.

PMID: 39689114 PMC: 11651551. DOI: 10.1371/journal.pone.0314856.


LungVis 1.0: an automatic AI-powered 3D imaging ecosystem unveils spatial profiling of nanoparticle delivery and acinar migration of lung macrophages.

Yang L, Liu Q, Kumar P, Sengupta A, Farnoud A, Shen R Nat Commun. 2024; 15(1):10138.

PMID: 39604430 PMC: 11603200. DOI: 10.1038/s41467-024-54267-1.


Multi-scenario surveillance of respiratory viruses in aerosols with sub-single-copy spatial resolution.

Li B, Lin B, Wang Y, Shi Y, Zeng W, Zhao Y Nat Commun. 2024; 15(1):8770.

PMID: 39384836 PMC: 11464689. DOI: 10.1038/s41467-024-53059-x.


SARS-CoV-2 infection and transmission via the skin to oro-nasal route with the production of bioaerosols in the ferret model.

Shipley R, Seekings A, Byrne A, Shukla S, James J, Goharriz H J Gen Virol. 2024; 105(9).

PMID: 39292223 PMC: 11410047. DOI: 10.1099/jgv.0.002022.


References
1.
Chao C, Wan M, Morawska L, Johnson G, Ristovski Z, Hargreaves M . Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci. 2020; 40(2):122-133. PMC: 7126899. DOI: 10.1016/j.jaerosci.2008.10.003. View

2.
Ma J, Qi X, Chen H, Li X, Zhang Z, Wang H . Coronavirus Disease 2019 Patients in Earlier Stages Exhaled Millions of Severe Acute Respiratory Syndrome Coronavirus 2 Per Hour. Clin Infect Dis. 2020; 72(10):e652-e654. PMC: 7499537. DOI: 10.1093/cid/ciaa1283. View

3.
Zhou L, Yao M, Zhang X, Hu B, Li X, Chen H . Breath-, air- and surface-borne SARS-CoV-2 in hospitals. J Aerosol Sci. 2020; 152:105693. PMC: 7557302. DOI: 10.1016/j.jaerosci.2020.105693. View

4.
Lednicky J, Lauzard M, Fan Z, Jutla A, Tilly T, Gangwar M . Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int J Infect Dis. 2020; 100:476-482. PMC: 7493737. DOI: 10.1016/j.ijid.2020.09.025. View

5.
Burton N, Grinshpun S, Reponen T . Physical collection efficiency of filter materials for bacteria and viruses. Ann Occup Hyg. 2006; 51(2):143-51. PMC: 7187796. DOI: 10.1093/annhyg/mel073. View